Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-16-163295)

Filing Details

Accession Number:: 0001104659-16-163295
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-12-21 19:14:22
Reporting Period:: 2016-12-19

Filing Date:: 2016-12-21
Accepted Time:: 2016-12-21 19:14:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1453687	Selecta Biosciences Inc	SELB	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1676904	Peter Keller	C/O Selecta Biosciences, Inc. 480 Arsenal Way Watertown MA 02472	Chief Business Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-12-19	4,723	$18.58	405	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

These shares are restricted common stock which are subject to a right of repurchase by the Issuer until December 31, 2016.